Free Trial

NovaBay Pharmaceuticals (NBY) Earnings Date, Estimates & Call Transcripts

NovaBay Pharmaceuticals logo
$0.72 +0.01 (+1.57%)
(As of 02:00 PM ET)

NovaBay Pharmaceuticals Latest Earnings Summary

Latest Q2 2024
Earnings Date
Aug. 13Estimated
Actual EPS
(Aug. 13)
-$1.37 Missed By -$1.37

NovaBay Pharmaceuticals announced Q2 2024 earnings on August 13, 2024, reporting an EPS of -$1.37. Quarterly revenue was reported to be $2.40 million. With a trailing EPS of -$9.95, NovaBay Pharmaceuticals' earnings are expected to grow next year, from ($2.54) to ($0.55) per share.

Get NovaBay Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovaBay Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NBY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovaBay Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.54) EPS
Next Year EPS Consensus Estimate: ($0.55) EPS

NovaBay Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/13/2024Q2 2024--$1.37 -$1.37-$1.37-$2.40M
5/9/2024Q1 2024--$0.14 -$0.14-$0.13-$2.63M
3/26/2024Q4 2023--$0.95 -$0.95-$0.57-$3.73M
11/9/2023Q3 2023--$0.37 -$0.37-$0.37-$3.27M
8/10/2023Q2 2023--$1.27 -$1.27-$1.27-$4.61M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M    
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
5/11/2023Q1 2023--$0.85 -$0.85-$0.85-$3.12M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
2024 Election Year Stocks: Uncover Hidden Gems! (Ad)

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M
3/30/2023Q4 2022--$4.33 -$4.33-$4.33-$3.64M

NovaBay Pharmaceuticals Earnings - Frequently Asked Questions

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on NBY's earnings history.

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) has a recorded annual revenue of $14.40 million.

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) has a recorded net income of -$10.61 million. NBY has generated -$9.95 earnings per share over the last four quarters.

NovaBay Pharmaceuticals's earnings are expected to grow from ($2.54) per share to ($0.55) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NYSEAMERICAN:NBY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners